DIU Thérapies ciblées en oncologie at Université Sorbonne Paris Nord

The DIU Thérapies ciblées en oncologie (Thérapies ciblées pour l'oncologie et les maladies inflammatoires chroniques) is an inter-university diploma with Université Paris Cité, aimed mainly at PhD students and practitioners. It teaches the pathophysiology and targeted treatments of cancers and chronic inflammatory diseases and how to build a research programme.

Faculty: UFR de santé, médecine et biologie humaine (SMBH)  |  Duration: 1 year  |  Intake: January to July (no classes in May); 2025-2026 had no enrolment, next session 2026-2027  |  Study mode: Continuing education; compulsory distance learning; taught in French  |  Location: Villetaneuse, Île-de-France, France

What you will study

90 hours delivered remotely in six seminars (2-3 days per month, January to July) across three modules: pathophysiology and target identification; pre-clinical and clinical drug development with examples of targeted treatments; targeted approaches for chronic inflammatory diseases and innovative approaches. Ends with a synthetic written work and oral defence.

Career pathways

Complement to initial training for doctors and pharmacists; supports recruitment as clinical research associate, physician in the pharmaceutical industry, and academic careers. For PhD students the hours can count towards their doctoral course, subject to doctoral school agreement.

Official programme page